Diane E Shevell

Title: Innovations in Autoimmune Disease Treatment by Diane E Shevell

Introduction

Diane E Shevell is a prominent inventor based in Westfield, NJ (US), known for her significant contributions to the field of autoimmune disease treatment. With a total of 3 patents, she has made remarkable strides in developing methods that address complex health issues.

Latest Patents

Her latest patents include innovative methods for treating systemic lupus erythematosus using a domain antibody directed against CD28. This method provides a treatment option that reduces symptoms of systemic lupus erythematosus compared to placebo. Another notable patent involves methods of treating autoimmune diseases using a domain antibody directed against CD40L. This approach targets various conditions, including primary immune thrombocytopenia, solid organ transplant rejection, and systemic sclerosis, among others. The antibody polypeptides developed do not activate platelets, offering a safer treatment alternative.

Career Highlights

Diane is currently associated with Bristol-Myers Squibb Company, where she continues to innovate in the field of immunology. Her work has been instrumental in advancing therapeutic options for patients suffering from autoimmune diseases.

Collaborations

Diane collaborates with esteemed colleagues such as Suzanne J Suchard and Marek Honczarenko, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Diane E Shevell's work exemplifies the impact of innovative thinking in the medical field, particularly in the treatment of autoimmune diseases. Her patents reflect a commitment to improving patient outcomes and advancing scientific knowledge.